Clinical and microbiological study on the impact of multidrug resistance on virulence and host response to Pseudomonas aeruginosa infection.
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: CONSORCI SANITARI MAR PARC DE HEALTH OF BARCELONA
- Execution start: 12/03/2020
- End of execution: 30/12/2022
- PI: CARMEN HIDALGO TENORIO